Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
scientific article published on 14 March 2018
Author/s
author: Hagop Kantarjian, Srdan Verstovsek, William G Wierda, Gautam Borthakur, Tapan Kadia, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Sherry Pierce, Guillermo Garcia-Manero, Marina Konopleva, Jorge Eduardo Cortes, Michael Andreeff, Naveen Pemmaraju, Miranda M Lim, Maro Ohanian
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.